Cargando…
Determination of the clearance factor for TSE agents during the manufacturing process of polygeline
Autores principales: | Penno, S, Reiner, G, Carbonatto, M, Bodenbender, L, Boland, P, Abel, KJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301850/ http://dx.doi.org/10.1186/cc522 |
Ejemplares similares
-
Effectiveness and Safety of Polygeline in Patients with Hypovolemia due to Trauma
por: Singh, Ajai, et al.
Publicado: (2017) -
Assessment of rVIIa as a universal haemostatic agent in a model of haemodilution
por: Chillala, S, et al.
Publicado: (2001) -
Polygeline in hypovolemia due to traumatic injury: Results of an open label study in Indian population
por: Singh, Ajai, et al.
Publicado: (2016) -
Cell-based medicinal products and the development of GMP-compliant processes and manufacturing
por: Romagnoli, Luca, et al.
Publicado: (2011) -
Follow up study in the assessment of rVlla as a universal haemostatic agent in a model of haemodilution
por: Chillala, S, et al.
Publicado: (2002)